Table 1 Clinical data of studied cases (No. 85)
From: Subtyping of high grade serous ovarian carcinoma: histopathological and immunohistochemical approach
Clinical parameter | Total number =85 | |
|---|---|---|
Age/years, mean±SD (min-max) | 52.78±8.63 (30.00–71.0) | |
Ascites N=57 | ||
 Negative | 25 | 43.9 |
 Positive | 32 | 56.1 |
CA 125 median (min-max) | 441.0 (52.0–13300.0) | |
Stage | N=85 | % |
 I | 12 | 14.1 |
 II | 5 | 5.9 |
 III | 67 | 78.8 |
 IV | 1 | 1.2 |
Treatment type | ||
 Primary DS followed by adjuvant therapy | 46 | 54.1 |
 NACT & IDS then adjuvant therapy | 39 | 45.9 |
Neo-adjuvant therapy type | ||
 Taxol carbo | 37 | 94.9 |
 Others | 2 | 5.1 |
Adjuvant therapy type | ||
 Taxol carbo | 76 | 89.4 |
 Others | 9 | 10.6 |
Total cycles | ||
 Median (min-max) | 6.0 (1.0–15.0) | |
Residual after debulking surgery | 16 | 18.8% |